Cargando…
Advances in designing Adeno-associated viral vectors for development of anti-HBV gene therapeutics
Despite the five decades having passed since discovery of the hepatitis B virus (HBV), together with development of an effective anti-HBV vaccine, infection with the virus remains a serious public health problem and results in nearly 900,000 annual deaths worldwide. Current therapies do not eliminat...
Autores principales: | Mnyandu, Njabulo, Limani, Shonisani Wendy, Arbuthnot, Patrick, Maepa, Mohube Betty |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670254/ https://www.ncbi.nlm.nih.gov/pubmed/34903258 http://dx.doi.org/10.1186/s12985-021-01715-9 |
Ejemplares similares
-
In Vivo Modelling of Hepatitis B Virus Subgenotype A1 Replication Using Adeno-Associated Viral Vectors
por: Limani, Shonisani Wendy, et al.
Publicado: (2021) -
Advances with RNAi-Based Therapy for Hepatitis B Virus Infection
por: van den Berg, Fiona, et al.
Publicado: (2020) -
Adenoviral Vectors: Potential as Anti-HBV Vaccines and Therapeutics
por: Farhad, Tasneem, et al.
Publicado: (2022) -
Progress and Prospects of Anti-HBV Gene Therapy Development
por: Maepa, Mohube B., et al.
Publicado: (2015) -
Gene Therapy for Chronic HBV—Can We Eliminate cccDNA?
por: Bloom, Kristie, et al.
Publicado: (2018)